Cargando…
Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
OBJECTIVE: This study aimed to explore the best treatment strategy for International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIA1 cervical cancer patients by comparing the survival outcomes of two treatment methods: abdominal radical hysterectomy (ARH) with standard postoperative t...
Autores principales: | Chen, Xiaolin, Liang, Wentong, Duan, Hui, Wu, Minling, Zhan, Xuemei, Dai, Encheng, Lv, Qiubo, Xie, Qinghuang, Liu, Ruilei, Xu, Yan, Bin, Xiaonong, Lang, Jinghe, Liu, Ping, Chen, Chunlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046906/ https://www.ncbi.nlm.nih.gov/pubmed/35494051 http://dx.doi.org/10.3389/fonc.2022.800049 |
Ejemplares similares
-
Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022) -
Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
por: Li, Zhiqiang, et al.
Publicado: (2022) -
Comparison of the Oncological Outcomes Between Robot-Assisted and Abdominal Radical Hysterectomy for Cervical Cancer Based on the New FIGO 2018 Staging System: A Multicentre Retrospective Study
por: Li, Pengfei, et al.
Publicado: (2022) -
Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study
por: Duan, Hui, et al.
Publicado: (2023) -
Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study
por: Ye, Yanna, et al.
Publicado: (2023)